Virtus Biotech ETF
11 hedge funds and large institutions have $4.47M invested in Virtus Biotech ETF in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
8% less funds holding
Funds holding: 12 → 11 (-1)
10.73% less ownership
Funds ownership: 36.46% → 25.73% (-11%)
37% less capital invested
Capital invested by funds: $7.13M → $4.47M (-$2.65M)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$379K |
| 2 |
MCC
Money Concepts Capital
Palm Beach Gardens,
Florida
|
+$9.89K |
| 3 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$4.73K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SMG
Smart Money Group
Eastland,
Texas
|
-$1.54M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$424K |
| 3 |
LPL Financial
San Diego,
California
|
-$283K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$118K |
| 5 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
-$5.16K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Royal Bank of Canada
Toronto,
Ontario, Canada
| $2.81M | -$424K | -9,864 | -13% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $601K | -$118K | -2,742 | -17% |
|
|
3
Citadel Advisors
Miami,
Florida
| $383K | +$379K | +8,811 | New |
|
|
FAIM
4
Financial Advocates Investment Management
Olympia,
Washington
| $368K | -$5.16K | -120 | -1% |
|
|
MIFH
5
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
| $121K | – | – | – |
|
6
Morgan Stanley
New York
| $90K | -$860 | -20 | -1% |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $52K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $22K | +$2.32K | +54 | +12% |
|
|
FWM
9
Focused Wealth Management
Newburgh,
New York
| $17K | – | – | – |
|
|
MCC
10
Money Concepts Capital
Palm Beach Gardens,
Florida
| $10K | +$9.89K | +230 | New |
|
|
PFS
11
Prospera Financial Services
Dallas,
Texas
| $5K | +$4.73K | +110 | New |
|
|
SMG
12
Smart Money Group
Eastland,
Texas
| – | -$1.54M | -31,469 | Closed |
|
|
13
LPL Financial
San Diego,
California
| – | -$283K | -5,795 | Closed |
|
|
MAM
14
Mystic Asset Management
Warwick,
Rhode Island
| – | -$1K | -25 | Closed |
|
BBP Hedge Fund Activity: Q1 2022 in Review
11 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q1 2022, worth a combined $4.47M — down 37% from $7.13M a quarter earlier.
Fund positioning in BBP was balanced in Q1 2022: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 4 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $379K. The largest seller was Smart Money Group, exiting entirely with an estimated $1.54M sold.
- 11 institutional investors held Virtus Biotech ETF (BBP) as of Q1 2022, down from 12 in Q4 2021.
- Funds reported $4.47M of Virtus Biotech ETF stock for Q1 2022, down 37% quarter-over-quarter.
- 3 funds opened new Virtus Biotech ETF positions in Q1 2022 and 3 closed out, a net change of 0 holders.
- The largest Virtus Biotech ETF buyer in Q1 2022 was Citadel Advisors, an estimated $379K added.
- The largest Virtus Biotech ETF seller in Q1 2022 was Smart Money Group, an estimated $1.54M sold.
Based on aggregated 13F filings for Q1 2022.